-
公开(公告)号:US10531891B2
公开(公告)日:2020-01-14
申请号:US13828383
申请日:2013-03-14
Applicant: The Spectranetics Corporation
Inventor: Wade A. Bowe , George Woodrow Burton , Paul Joseph Dalby , Kenneth P. Grace , Ryan Michael Sotak , Blaine Andrew Schneider
IPC: A61B18/24 , A61B17/3207 , A61N1/05 , A61B90/00 , A61B17/3203 , A61B17/3211 , A61B17/50 , H04L29/06 , H04M3/56 , A61B17/32
Abstract: Methods and systems for separating an object, such as a lead, from formed tissue are provided. Specifically, a tissue slitting device is configured to engage patient formed tissue at a slitting engagement point. While the object is subjected to a first traction force, the tissue slitting device is caused to move further into the engaged tissue and slit the tissue past the point of engagement. The slitting device causes the tissue to separate along an axial direction of the length of the formed tissue and releases at least some of the force containing the object. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.
-
公开(公告)号:US10368900B2
公开(公告)日:2019-08-06
申请号:US15229873
申请日:2016-08-05
Applicant: The Spectranetics Corporation
Inventor: Wade A. Bowe , George Woodrow Burton , Paul Joseph Dalby , Ryan Michael Sotak , Matthew Allan James
IPC: A61B17/3207 , A61N1/05 , A61B90/00 , A61B17/3203 , A61B17/3211 , A61B17/50 , A61B18/24 , G10L21/00 , H04L29/06 , H04M3/56 , A61B17/32
Abstract: Methods and systems for separating an object, such as a lead, from formed tissue are provided. Specifically, a tissue slitting device is configured to engage patient formed tissue at a slitting engagement point. While the object is subjected to a first traction force, the tissue slitting device is caused to move further into the engaged tissue and slit the tissue past the point of engagement. The slitting device causes the tissue to separate along an axial direction of the length of the formed tissue and releases at least some of the force containing the object. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.
-
公开(公告)号:US20180214175A1
公开(公告)日:2018-08-02
申请号:US15940548
申请日:2018-03-29
Applicant: The Spectranetics Corporation
Inventor: Wade A. Bowe , George Woodrow Burton , Paul Joseph Dalby , Ryan Michael Sotak
IPC: A61B17/3207 , H04M3/56 , A61B90/00 , G10L21/00 , A61B17/3203 , A61N1/05 , A61B18/24 , A61B17/50 , A61B17/3211 , A61B17/32
CPC classification number: A61B17/32075 , A61B17/3203 , A61B17/32037 , A61B17/3207 , A61B17/320725 , A61B17/3211 , A61B17/50 , A61B18/245 , A61B90/02 , A61B2017/320004 , A61B2017/320044 , A61N1/05 , A61N1/056 , A61N1/057 , A61N2001/0578 , F04C2270/041 , G10L21/00 , H04L65/403 , H04M3/568
Abstract: Methods and systems for separating an object, such as a lead, from formed tissue are provided. Specifically, a tissue slitting device is configured to engage patient formed tissue at a slitting engagement point. While the object is subjected to a first traction force, the tissue slitting device is caused to move further into the engaged tissue and slit the tissue past the point of engagement. The slitting device causes the tissue to separate along an axial direction of the length of the formed tissue and releases at least some of the force containing the object. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.
-
公开(公告)号:US20170325835A1
公开(公告)日:2017-11-16
申请号:US15666338
申请日:2017-08-01
Applicant: The Spectranetics Corporation
Inventor: Wade A. Bowe , George Woodrow Burton , Paul Joseph Dalby , Ryan Michael Sotak
IPC: A61B17/3207 , A61B90/00 , G10L21/00 , H04L29/06 , A61B17/3203 , A61N1/05 , A61B18/24 , A61B17/50 , A61B17/3211 , H04M3/56 , A61B17/32
CPC classification number: A61B17/32075 , A61B17/3203 , A61B17/32037 , A61B17/3207 , A61B17/320725 , A61B17/3211 , A61B17/50 , A61B18/245 , A61B90/02 , A61B2017/320004 , A61B2017/320044 , A61N1/05 , A61N1/056 , A61N1/057 , A61N2001/0578 , F04C2270/041 , G10L21/00 , H04L65/403 , H04M3/568
Abstract: Methods and systems for separating an object, such as a lead, from formed tissue are provided. Specifically, a tissue slitting device is configured to engage patient formed tissue at a slitting engagement point. While the object is subjected to a first traction force, the tissue slitting device is caused to move further into the engaged tissue and slit the tissue past the point of engagement. The slitting device causes the tissue to separate along an axial direction of the length of the formed tissue and releases at least some of the force containing the object. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.
-
-
-